LIPOCINE INC. Payments of Stock Issuance Costs
LIPOCINE INC. (LPCN) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2017-03-06
- LIPOCINE INC. payments of stock issuance costs for the quarter ending 2015-12-31 was $0.00.
- LIPOCINE INC. payments of stock issuance costs for the quarter ending 2015-09-30 was $0.00.
- LIPOCINE INC. payments of stock issuance costs for the quarter ending 2015-06-30 was $0.00.
- LIPOCINE INC. payments of stock issuance costs for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. payments of stock issuance costs for fiscal 2016 was $0.00.
- LIPOCINE INC. payments of stock issuance costs for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- LIPOCINE INC. payments of stock issuance costs for fiscal 2014 was $271.18K.
- LIPOCINE INC. payments of stock issuance costs for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-06 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $0.00 derived: sum of 2 quarters · filed 2017-03-06 | $0.00 derived: sum of 3 quarters · filed 2017-03-06 | $0.00 10-K · filed 2017-03-06 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | $0.00 derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $0.00 10-Q · filed 2015-08-11 | $0.00 derived: sum of 3 quarters · filed 2017-03-06 | $0.00 derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2017-03-06 | $0.00 derived: sum of 3 quarters · filed 2017-03-06 | $0.00 derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $0.00 derived: sum of 2 quarters · filed 2017-03-06 | $0.00 derived: sum of 3 quarters · filed 2017-03-06 | $271.18K 10-K · filed 2017-03-06 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $271.18K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $271.18K 10-Q · filed 2015-08-11 | ||
| 2014-03-31 | $271.18K 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-03-11 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $9.50K 10-K · filed 2013-02-26 | ||
| 2012-09-30 | $9.50K 10-Q · filed 2012-10-26 | $0.00 10-Q · filed 2012-10-26 | ||
| 2011-12-31 | -$9.50K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$9.50K 10-K · filed 2013-02-26 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |